Oncology & Cancer

Merck KGaA suffers setback on cancer drug

German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.

Oncology & Cancer

Japan's DSP to buy US cancer start-up for $2.6 bn

Japanese drugs giant Dainippon Sumitomo Pharma will buy US biotechnology cancer specialist Boston Biomedical for a price that could hit $2.6 billion, the companies announced Thursday.

Vaccination

Rwanda breaks ground on first mRNA vaccine plant

Rwanda and German pharma company BioNTech broke ground Thursday on Africa's first mRNA vaccine factory where cutting-edge treatments for diseases like COVID-19 will be made for millions across the continent.

page 2 from 2